Big strides in cancer detection and treatment from the tiniest technologies
The MIT Marble Center for Cancer Nanomedicine looks back at 10 years of turning big ideas about nanotechnology into transformative advances for cancer patients.
Beacon Biosignals is mapping the brain during sleep
Founded by Jake Donoghue PhD ’19 and former MIT researcher Jarrett Revels, the company is creating an AI-driven platform to help diagnose and treat disease.
Two MIT alumnae named 2026 Gates Cambridge Scholars
Mitali Chowdhury ’24 and Christina Kim ’24 will pursue graduate studies at Cambridge University in the UK.
How bacteria suppress immune defenses in stubborn wound infections
Study finds a common bacterium can suppress the body’s early warning system in wounds, causing infections to persist and create an environment that allows other bacteria to take hold.
Turning muscles into motors gives static organs new life
A new biohybrid system developed at MIT is the first living implant that uses rewired nerves to revive paralyzed organs.
MIT engineers design proteins by their motion, not just their shape
An AI model generates novel proteins based on how they vibrate and move, opening new possibilities for dynamic biomaterials and adaptive therapeutics.
Bridging medical realities in the study of technology and health
Anthropologist Amy Moran-Thomas studies overlooked insights from people health care is meant to reach.
After 16 years leading Picower Institute, Li-Huei Tsai will sharpen focus on research, teaching
Tsai, who has grown the MIT neuroscience institute, will increase focus on research including Alzheimer’s disease and Down syndrome.
New sensor sniffs out pneumonia on a patient’s breath
The technology could enable fast, point-of-care diagnoses for pneumonia and other lung conditions.
Can AI help predict which heart-failure patients will worsen within a year?
Researchers at MIT, Mass General Brigham, and Harvard Medical School developed a deep-learning model to forecast a patient’s heart failure prognosis up to a year in advance.
3 Questions: Building predictive models to characterize tumor progression
Assistant Professor Matthew Jones is working to decode molecular processes on the genetic, epigenetic, and microenvironment levels to anticipate how and when tumors evolve to resist treatment.
Injectable “satellite livers” could offer an alternative to liver transplantation
The engineered tissue grafts could take on the liver’s function and help thousands of people with liver failure.
MIT-Royalty Pharma Faculty Founder Initiative supports biotech innovators
Offering substantial prize funding alongside workshops, classes, and mentorship, the initiative helps translate early-stage biotech research into venture-ready innovation.
Fragile X study uncovers brain wave biomarker bridging humans and mice
Researchers find mice modeling the autism spectrum disorder fragile X syndrome exhibit the same pattern of differences in low-frequency waves as humans — a new marker for treatment studies.
Bridging science and society in the emerging bioeconomy
In STS.059 (The Bioeconomy and Society), students explore the social and political factors at work in the biology, biotech, and biological engineering sectors.